Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 2:06 PM
Ignite Modification Date: 2025-12-25 @ 12:49 PM
NCT ID: NCT01198795
Description: None
Frequency Threshold: 5
Time Frame: Adverse event data was collected during a 28 month period from October 2010 to February 2013.
Study: NCT01198795
Study Brief: Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Escitalopram Flexible-dose 10mg-20mg once-daily oral (10mg tablets) dose of escitalopram for 24-weeks, with a 2-week downtaper period. None None 2 118 59 118 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Mania SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (15.1) View
Suicidal Ideation SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (15.1) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Abdominal pain upper SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (15.1) View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (15.1) View
Nausea SYSTEMATIC_ASSESSMENT General disorders MedDRA (15.1) View
Vomiting SYSTEMATIC_ASSESSMENT General disorders MedDRA (15.1) View
Nasopharyngitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (15.1) View
Increased appetite SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (15.1) View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (15.1) View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (15.1) View
Insomnia SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (15.1) View
Nasal congestion SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (15.1) View